Elicio Therapeutics (ELTX) EBT (QoQ) (2020 - 2026)
Elicio Therapeutics (ELTX) EBT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Elicio Therapeutics | 58.60 Mn | 35.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.89% |
| Mar 31, 2026 | -139.62% |
| Dec 31, 2025 | 50.03% |
| Sep 30, 2025 | -10.42% |
| Jun 30, 2025 | -53.20% |
| Mar 31, 2025 | 15.39% |
| Dec 31, 2024 | -24.66% |
| Sep 30, 2024 | 45.34% |
| Jun 30, 2024 | -77.38% |
| Mar 31, 2024 | -8.70% |
| Dec 31, 2023 | 50.45% |
| Sep 30, 2023 | -75.30% |
| Jun 30, 2023 | -38.05% |
| Mar 31, 2023 | -34.59% |
| Dec 31, 2022 | 40.81% |
| Sep 30, 2022 | -39.39% |
| Jun 30, 2022 | 50.46% |
| Mar 31, 2022 | -203.44% |
| Dec 31, 2021 | 134.89% |
| Sep 30, 2021 | 7.73% |